Atlas Trials

A Practical Clinical Study Comparing the Fixed-cycle Regimen Containing Orelabrutinib With BTKi Monotherapy

Clinical trial NCT06476899 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06476899
Sponsor
Fei Li
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
CLL/SLL
Start date
2024-07-24
Primary completion
2026-03-26
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.